← All organizations

Galera Therapeutics

For profitWebsite ↗

Also known as: Galera Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 7, 2021

Timeline

2000s

Jun 1, 2009
Galera Therapeutics— Founded

Drugs by trial phase (5 distinct, 17 trials)

Phase 3 (1 own, 0 via acquisition)

Avasopasem

Phase 2 (1 own, 0 via acquisition)

gc4711

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (24)

NCT04698915Lead sponsorPhase 2May 7, 2021
NCT04476797Lead sponsorPhase 1/Phase 2Oct 18, 2020
NCT04555096Lead sponsorPhase 2Sep 9, 2020
NCT04529850Lead sponsorPhase 2Jun 30, 2020
NCT04225026Lead sponsorPhase 2Dec 19, 2019
NCT03762031Study chairPhase 1Apr 30, 2019
NCT03762031Lead sponsorPhase 1Apr 30, 2019
NCT05412472Lead sponsorPhase 1Apr 4, 2019
NCT03792971Lead sponsorPhase 1Feb 10, 2019
NCT03689712Lead sponsorPhase 3Oct 31, 2018
NCT03340974Study chairPhase 1/Phase 2Feb 12, 2018
NCT03340974Lead sponsorPhase 1/Phase 2Feb 12, 2018
NCT03099824Lead sponsorPhase 1Oct 1, 2017
NCT03194139Lead sponsorPhase 1Sep 1, 2017
NCT03194139Study chairPhase 1Sep 1, 2017

Details

Founded: Malvern, PA, US Jun 1, 2009
Last known activity: May 7, 2021